1. Home
  2. CNSP vs SEGG Comparison

CNSP vs SEGG Comparison

Compare CNSP & SEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$6.09

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo Lottery.com Inc.

SEGG

Lottery.com Inc.

HOLD

Current Price

$1.86

Market Cap

3.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNSP
SEGG
Founded
2017
N/A
Country
United States
United States
Employees
N/A
12
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.6M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
CNSP
SEGG
Price
$6.09
$1.86
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
73.0K
N/A
Earning Date
11-17-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.93
N/A
52 Week High
$114.00
N/A

Technical Indicators

Market Signals
Indicator
CNSP
SEGG
Relative Strength Index (RSI) 45.58 66.33
Support Level $5.75 $0.46
Resistance Level $7.51 $4.65
Average True Range (ATR) 0.72 0.53
MACD 0.09 0.20
Stochastic Oscillator 22.58 34.15

Price Performance

Historical Comparison
CNSP
SEGG

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About SEGG Lottery.com Inc.

Lottery.com Inc is a provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

Share on Social Networks: